Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension

In a prospective registry prevalent and incident patients diagnosed with group 1 to 5 pulmonary hypertension will be enrolled. In an integrated biobank body fluid samples will be collected at enrollment and sequentially during treatment with targeted drugs for pulmonary hypertension.